BRCA1 and obesity due to melanocortin 4 receptor deficiency: In the biomedical domain, research often revolves around important bio-entities, such as diseases (e.g., Alzheimer's disease, Obesity, depression), drugs (e.g., metformin (Diabetes), troglitazone (Diabetes), Amitriptyline (Depression)), and genes (e.g., BRCA1 (Breast Cancer), APP (Alzheimer's disease), and LEP (Obesity)) [78].